Microbiology Exam test 1 chapters 1&3 review

Fungi and the Human Microbiome

  • Fungal Distribution in the Body

    • Normal fungi are consistently present but are generally outcompeted by bacteria.
    • The highest concentrations of fungi in the human body are found on the bottom of the feet and the hands.
    • Fungi are typically not found residing on the eye, the hair, or the tongue.
    • Yeast (a type of fungus) is present on the teeth; this was previously confirmed through negative staining techniques.
  • Microbial Competition and Antibiotics

    • Fungal overgrowth occurs when the bacterial population is destroyed, typically by antibiotic treatment.
    • Common results of bacterial destruction include:
      • Vaginal yeast infections.
      • Fungal overgrowth of the intestines (observed in patients treated for long periods with antibiotics for C. diff/CDP seal).
  • Pathogenicity of Fungi

    • Fungi are generally not considered highly pathogenic or virulent in their own right.
    • Illness resulting from fungi usually stems from:
      • Toxins released by the fungi.
      • Allergic reactions (e.g., redness or scalding sensations in skin folds).
      • Opportunistic infections in immunocompromised individuals (e.g., cancer patients or those on heavy antibiotics).
    • If a patient presents with a significant fungal infection, clinicians must investigate the underlying cause, as healthy immune systems usually keep fungal growth in check.

Antibiotics, Protozoa, and Misconceptions

  • Definition and Function of Antibiotics

    • By definition, antibiotics are substances produced by fungi and bacteria to inhibit the growth of other bacteria and fungi.
    • Antibiotics are biological tools used by microbes to maintain their own niche (milieu).
    • Antibiotics are notably ineffective against protozoa because protozoa do not typically compete with bacteria or fungi for resources in a way that requires that biological response.
  • Misleading Information in Medical Media

    • There is a significant misconception regarding the treatment of Cryptosporidiosis (a protozoan disease).
    • News reports and even some physician-targeted applications (such as Open Evidence) may incorrectly suggest that antibiotics treat protozoan infections.
    • Proper treatment requires an anti-protozoal medication, which is distinct from an antibiotic.

Pathogens and Emergent Diseases

  • Virulent E. coli

    • Escherichia coli O157:H7 is identified as a virulent, emergent disease implicated in many deaths.
    • The nomenclature "O157:H7" refers to specific markers:
      • O157: Refers to the cell wall polysaccharide index.
      • H7: Refers to the flagella type.
  • Prions

    • Prions are the causative agents of Mad Cow Disease (Boviform Spongiform Encephalopathy).
    • Prions are not bacteria. If they were bacteria, they would be significantly easier to treat.
  • Historical Microbiology

    • Robert Koch did not use E. coli to establish his postulates.
    • Koch utilized Anthrax because it was the "domestic dollar" issue of the era, causing significant mortality in livestock.

Sterility and Membranes

  • Serous vs. Mucous Membranes
    • Serous Membranes: These must always be sterile. Any laboratory report showing microbial growth on a serous membrane is indicative of a serious infection.
    • Mucous Membranes: These are not sterile and naturally host normal flora. Examples include the throat, nose, ear, and eye.

Cellular Size, Measurement, and Biotechnology

  • Microbial Scale

    • 1μm1\,\mu m (one micron or micrometer) is equivalent to 106m10^{-6}\,m.
    • Organisms/structures approximately one micron in size include typical bacteria and mitochondria.
    • Viruses are significantly smaller than one micron (109m10^{-9}\,m range).
  • Mathematical Operations in Measurement

    • When multiplying exponents, the values are added.
    • Example: A micron (10610^{-6}) times a micron (10610^{-6}) equals 101210^{-12}.
    • A nanometer is defined as 109m10^{-9}\,m.
  • Biotechnology

    • While many consider biotechnology to encompass all uses of microorganisms for products, its most specific definition is the development of recombinant DNA.
    • Bioremediation is a sub-field, exemplified by the use of oil-degrading bacteria to clean up oil spills.

Protozoa and Archaea Characterization

  • Protozoa Characteristics

    • Classification: Eukaryotic, unicellular, and highly diverse.
    • Locomotion: They move via pseudopods, flagella, or cilia.
    • Cell Structure: They lack rigid cell walls, which allows for their motility.
    • Genetics: They contain eukaryotic structures but may have specific circular DNA elements in organelles.
  • Archaea

    • Archaea represent their own evolutionary line and are not derived from bacteria.
    • They are known for existing in extreme environments and have remained relatively unchanged.

Clinical Staging of Syphilis and Lyme Disease

  • Syphilis Staging

    • Primary: Formation of a chancre.
    • Secondary: (General progression).
    • Tertiary: Neurological complications.
  • Lyme Disease Staging

    • Primary: Bull's-eye rash (Erythema migrans).
    • Secondary: General rash.
    • Tertiary: Neurological complications.

Vaccination Limits

  • Vaccines are primarily developed to target toxins and viruses.
  • There are currently very few or no vaccines effectively used against fungi and protozoa in standard clinical practice.

Mathematics in Nursing and Clinical Safety

  • Institutional Requirements

    • Nursing students are often required to pass calculation tests every semester.
    • Failure to pass these tests (often allowing three attempts per semester) can result in being withdrawn from the program due to the high risk of medication errors.
  • The Sydney Farber Case Study (Case of Dosage Error)

    • A significant medical error occurred at the Sydney Farber Cancer Institute involving a patient who was a writer for the Boston Globe.
    • The patient was accidentally administered a dose that was 10610^{6} (one million) times the intended amount of a chemotherapeutic agent.
    • The error persisted for approximately three weeks.
    • Systemic Failure: The error was written incorrectly, filled incorrectly by the pharmacist at a million times the dose, and administered by 12 different nurses over those weeks.
    • Outcome: The patient died, and all 12 nurses involved had their licenses suspended and were required to undergo remediation.
    • Critical Lesson: Distinguishing between a microgram and a milligram is a life-or-death calculation.